期刊文献+

CD147、NF-κB在食管鳞状细胞癌组织中的表达及意义 被引量:3

The significance and expression of CD147 and NF-κB in esophageal squamous cell carcinoma
原文传递
导出
摘要 目的 研究基质金属蛋白酶刺激因子(CD147)、核转录因子-κB[NF-κB(p65)]在食管鳞状细胞癌组织中的表达及其在食管鳞癌侵袭转移的作用及可能机制.方法 应用免疫组织化学方法检测40例食管鳞癌患者癌组织及其癌旁正常对照组织CD147、NF-κB的表达.结果 CD147、NF-κB在食管鳞癌表达阳性率为77.5%、87.5%,在癌旁正常对照组为25%、42.5%,2组差异有统计学意义(P<0.05);CD147在早期和中晚期食管癌表达阳性率为33.3%、90.3%,在NF-κB为55.6%、96.8%,2组差异均有统计学意义(P<0.05);CD147在食管鳞癌无转移和转移组表达阳性率为28.6%、87.9%,在NF-κB为42.9%、97%,2组差异均有统计学意义(P<0.05).结论 CD147、NF-κB在食管鳞癌组织表达增高,与肿瘤的浸润、转移相关,它们可能是通过共同的作用途径来实现的. Objective To investigate the expression of extracellular matrix metalloproteinase inducer (CD147), nuclear factor kappa B (NF-κB) in esophageal squamous cell carcinoma tissue and probe their relationship to invasion and metastasis of esophageal carcinoma. Methods Immunochemical staining was performed to detect the expression of CD147 and NF-κB protein in 40 cases of esophageal carcinoma tissues and 40 cases of normal control. Results The positive rate of CD147 and NF-κB in esophageal carcinoma tissues and in adjacent noncancerous tissues were 77.5%/87.5% Vs 25%/42. 5%, P〈0.05.The positive rate of their prophase and metaphase-advanced stage esophageal carcinoma tissues were 33.3%/90.3% Vs 55.6%/96.8%, P〈0.05..The positive rate of non-metastatic and metastatic esophageal carcinoma tissues were 28.6%/87.9% Vs 42.9%/97%, P〈0.05.Conclusions Our results suggested that the increased expression of CD147 and NF-κB contributed to tumor angiogenesis in esophageal squamous cell carcinoma, which might be through the common pathway.
出处 《中国医师杂志》 CAS 2010年第9期1171-1173,共3页 Journal of Chinese Physician
关键词 抗原 CD147/代谢 NF-κB/代谢 食管肿瘤/代谢 鳞状细胞/代谢 Antigens,CD147/ME NF-kappa B/ME Esophageal neoplasms/ME Carcinoma,squamous cell/ME
  • 相关文献

参考文献6

  • 1刘志平,赵文辉,朱宪明,冀文茹,刘凤兰,赵龙,王坚.食管鳞癌组织中p57^kip2、cyclin D1和PCNA的表达及意义[J].中国医师杂志,2007,9(12):1585-1588. 被引量:3
  • 2Mariette C,Finzi L,Fabre S,et al.Factors predictive of complete resection of oper-able esophageal cancer:a prospective study.Ann Thorac Surg,2003,75(6):1720-1726.
  • 3Kuang YH,Chen X,Su I,et al.Proteome Analysis of Multidrug Resistance of Human Oral Squamous Careinnma Cells Using CD147 Siencing.Proteome Res,2008,7(11):4784-4791.
  • 4Tan H,Ye K,Wang Z,Tang H.CD147 expression asasignificant prognosic factor in differentiated thyroid carcinoma.Transl Res,2008,152(3):143-149.
  • 5Aggarwal B B,Nuclear factor kappa B,the enemy with.Cancer Cell,2004,6(3):203-208.
  • 6Perkins ND.NF-kappa B:tumor promoter or Suppressor.Trends Cell Biol,2004,14(2):64-69.

二级参考文献7

  • 1Matsuooka S,Edwards MS,Bai C,et al.p57^kip2 structurally distinct member of the p21cip1-CDK inhibitor family,is a candicate tumor suppressor gene.Gene Dev,1995,9(6):650-662.
  • 2Yokoo T,Toyoshima H,Miura M,et al.p57^kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus.Biol Chem,2003,278(52):52919-52923.
  • 3Matsumoto M,Farihata M,Ohsuki Y,et al.Immunohistochemical characterization of p57^kip2 expression in human esophageal squamous cell carcinoma.Anticancer Res,2000,20(3B):1947-1952.
  • 4Sui L,Dong Y,Ohno M,et al.Expression of p57^kip2 and its clinical relevace in epithelial ovarian tumors.Anticancer Res,2002,22(6A):3191-3196
  • 5Ito Y,Takeda T,Sasaki Y,et al.Expression of p57^kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma.Liver,2002,22(2):145-149.
  • 6Taftachi R,Ayhan A,Ekici S,et al.Proliferating-cell nuclear antige(PCNA)as an independent prognostic marker in patients after prostatectomy:a comparison of PCNA and ki-67.BJU Int,2005,94(4):650-654.
  • 7岳辉,张宁,冯新莉,麻树人,宋福林,杨明,唐谊海.胰腺癌组织中p57^(kip2)、cyclin E和PCNA表达与临床病理因素的关系[J].癌症,2003,22(7):705-709. 被引量:11

共引文献2

同被引文献15

  • 1Min Su~1 Shan-Ming Lu~1 Dong-Ping Tian~1 Hu Zhao~1 Xiao-Yun Li~2 De-Rui Li~3 Zhi-Chao Zheng~4 1 Department of Pathology,2 Tumor Hospital,3,4 Second Teaching Hospital,Shantou University Medical College,Shantou 515031,China.Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China[J].World Journal of Gastroenterology,2001,7(5):657-661. 被引量:20
  • 2Zhang BG,Li JF,Yu BQ. MicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN[J].Oncology Reports,2012,(04):1019-1026.
  • 3Ren Y,Zhou X,Mei M. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229(PTEN-wild type) to taxol[J].BMC Cancer,2010.27.
  • 4Schetter AJ,Leung SY,Sohn JJ. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colonadenocarcinoma[J].Journal of the American Medical Association,2008,(04):425-436.
  • 5Yamamichi N,Shimomura R,Inada K. Locked nucleic acid in situ hybridization analysis of miR-21 expressionduring colorectal cancer development[J].Clinical Cancer Research,2009,(12):4009-4016.
  • 6Mueller S,Phillips J,Onar-Thomas A. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomasand influence on clinical outcome[J].Journal of Neuro-Oncology,2012,(09):1146-1152.
  • 7White MJ,Schoenwaelder SM,Josefsson EC. Caspase-9mediates the apoptotic death of megakaryocytes and platelets,but is dispensable for their generation and function[J].Blood,2012,(18):4283-4290.
  • 8梁旭东,杜焕社,史晓锋.Survivin、PTEN在胃癌中的表达及临床意义[J].中国医师杂志,2009,11(7):901-903. 被引量:4
  • 9娄艳辉,杨兴升,王福玲,钱金花,黄煜.miR-21在上皮性卵巢癌组织中的表达及临床意义[J].南方医科大学学报,2010,30(3):608-610. 被引量:14
  • 10陈卫昌,林茂松,黄俊星,叶玉兰,郜恒骏,宋振云,沈晓莹.人结直肠癌微小核糖核酸的差异表达及其临床意义[J].世界华人消化杂志,2010,18(30):3187-3194. 被引量:3

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部